Growth Metrics

Eli Lilly (LLY) Assets (2009 - 2026)

Eli Lilly posted quarterly Assets of $116.6 billion for Q1 2026, up 30.41% year-on-year from $89.4 billion in Q1 2025, and up 3.65% on a QoQ basis from $112.5 billion in Q4 2025.

Eli Lilly (LLY) has 18 years of Assets data on file, last reported at $116.6 billion in Q1 2026.

  • For the quarter ending Q1 2026, Assets rose 30.41% year-over-year to $116.6 billion; the trailing twelve-month figure through Mar 2026 stood at $116.6 billion (up 30.41% YoY), and the FY2025 full-year result was $112.5 billion, up 42.89% from the prior year.
  • Assets for Q1 2026 stood at $116.6 billion, up from $112.5 billion in the prior quarter.
  • Across five years, Assets topped out at $116.6 billion in Q1 2026 and bottomed at $46.9 billion in Q1 2022.
  • The 5-year median for Assets is $64.0 billion (2023), against an average of $73.3 billion.
  • The widest annual swing landed in 2022, when Assets decreased 1.56%; it then jumped 52.02% in 2025.
  • A 5-year view of Assets shows it stood at $49.5 billion in 2022, then increased by 29.33% to $64.0 billion in 2023, then increased by 22.98% to $78.7 billion in 2024, then surged by 42.89% to $112.5 billion in 2025, then grew by 3.65% to $116.6 billion in 2026.
  • The last three Assets figures came in at $116.6 billion (Q1 2026), $112.5 billion (Q4 2025), and $114.9 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 116.58 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 200.89 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 136.46 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 128.69 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 92.50 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 56.28 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 208.00 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 86.48 Bn
10 Gsk 88.34 Bn 83.66 Bn - 81.30 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 116.58 Bn
Dec 31, 2025 112.48 Bn
Sep 30, 2025 114.94 Bn
Jun 30, 2025 100.92 Bn
Mar 31, 2025 89.39 Bn
Dec 31, 2024 78.72 Bn
Sep 30, 2024 75.61 Bn
Jun 30, 2024 71.87 Bn
Mar 31, 2024 63.94 Bn
Dec 31, 2023 64.01 Bn
Sep 30, 2023 57.92 Bn
Jun 30, 2023 54.81 Bn
Mar 31, 2023 53.16 Bn
Dec 31, 2022 49.49 Bn
Sep 30, 2022 47.46 Bn
Jun 30, 2022 47.06 Bn
Mar 31, 2022 46.92 Bn
Dec 31, 2021 48.81 Bn
Sep 30, 2021 48.19 Bn
Jun 30, 2021 47.81 Bn
Mar 31, 2021 46.84 Bn
Dec 31, 2020 46.63 Bn
Sep 30, 2020 43.95 Bn
Jun 30, 2020 41.97 Bn
Mar 31, 2020 41.10 Bn
Dec 31, 2019 39.29 Bn
Sep 30, 2019 37.89 Bn
Jun 30, 2019 38.67 Bn
Mar 31, 2019 38.01 Bn
Dec 31, 2018 43.91 Bn
Sep 30, 2018 44.63 Bn
Jun 30, 2018 42.36 Bn
Mar 31, 2018 44.36 Bn
Dec 31, 2017 44.98 Bn
Sep 30, 2017 43.01 Bn
Jun 30, 2017 40.95 Bn
Mar 31, 2017 37.62 Bn
Dec 31, 2016 38.81 Bn
Sep 30, 2016 37.59 Bn
Jun 30, 2016 36.48 Bn
Mar 31, 2016 34.69 Bn
Dec 31, 2015 35.57 Bn
Sep 30, 2015 36.30 Bn
Jun 30, 2015 36.04 Bn
Mar 31, 2015 35.65 Bn
Dec 31, 2014 36.31 Bn
Sep 30, 2014 34.65 Bn
Jun 30, 2014 35.02 Bn
Mar 31, 2014 34.76 Bn
Dec 31, 2013 35.25 Bn
Sep 30, 2013 33.97 Bn
Jun 30, 2013 33.23 Bn
Mar 31, 2013 32.30 Bn
Dec 31, 2012 34.40 Bn
Sep 30, 2012 34.32 Bn
Jun 30, 2012 31.81 Bn
Mar 31, 2012 32.24 Bn
Dec 31, 2011 33.66 Bn
Sep 30, 2011 33.04 Bn
Jun 30, 2011 32.78 Bn
Mar 31, 2011 31.70 Bn
Dec 31, 2010 31.00 Bn
Sep 30, 2010 29.90 Bn
Jun 30, 2010 27.72 Bn
Mar 31, 2010 27.20 Bn
Dec 31, 2009 27.46 Bn
Sep 30, 2009 18.90 Bn
Jun 30, 2009 26.93 Bn